GRAMD1B and Ito hypomelanosis: Besides preclinical PK/PD-studies [65–67], clear data on target levels for LAmB in ICU patients with IPA do not exist and are further complicated by different LAmB kinetics in tissue und serum as well as accumulation in lung tissue [68, 69].